The Conversation (0)
Reuters UK reported that Intercept Pharmaceuticals Inc is in the midst of exploring a potential sale after receiving interest from other companies, according to people familiar with the matter.
Reuters UK reported that Intercept Pharmaceuticals Inc is in the midst of exploring a potential sale after receiving interest from other companies, according to people familiar with the matter.
According to the article:
Intercept has been working with investment bankers to explore the prospect of a sale, the people said this week, cautioning that there was no certainty on whether the company would decide to proceed with any transaction.
Latest News
Outlook Reports world
Featured Biotech Investing Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES